About the company

Visma is a leading provider of mission-critical enterprise resource planning, accounting, payroll and transaction process outsourcing software to small and medium-sized businesses and to the public sector in Northern Europe.

The investment rationale

Hg saw an opportunity to invest in a company with strong year-on-year growth underpinned by the ongoing shift towards greater digitalisation and process automation, a succession of new customer wins and scale built through over 80 add-on acquisitions.

Software is a core sector for Hg and the manager has deep knowledge of both the sector and the company, having owned Visma across its funds over the past decade.

Our relationship

Pantheon has a long-standing relationship with Hg, having made primary commitments to its funds since 2006. PIP co-invested in three other transactions alongside Hg.

About the company

KD Pharma Group is a leading global producer of Omega-3 ingredients focused on highly purified Omega-3 fatty acids for pharmaceutical and nutraceutical products.

Investment rationale

KD Pharma Group is a market-leading business with key competitive advantages based on patented technology and processes. The company has an integrated supply chain that facilitates margin benefits, a strong repeat client base, and a strong brand based upon being a reliable and consistent producer of high-quality Active Pharmaceutical Ingredients (APIs).

KD Pharma has grown from a single-digit revenue business to one of the industry’s largest players.

Our relationship

PIP’s long-standing relationship with German mid-market buyout firm capiton, which started with a series of primary investments, has enabled PIP to participate in this attractive investment opportunity.

About the company

Juice Plus is a direct seller of whole food-based nutritional products including fruit and vegetable capsules and nutritional shakes.

By investing in Juice Plus alongside Altamont Capital Partners, PIP intends to capitalise on consumer lifestyle changes driven by healthy eating trends.

About the company

MediFox is a leading provider of software solutions to over 6,000 ambulatory care services, elderly care homes and therapists in Germany. Key services include resource and route planning, care documentation, as well as billing and administration services.

We invested in Medifox alongside Hg Capital to gain exposure to a recurring revenue business that is able to respond to demographic trends in Germany, such as the shift to outpatient care and efforts to increase productivity in healthcare.

Page 4 of 4
1 2 3 4

Disclaimer

THE WEBSITE YOU ARE SEEKING TO ACCESS IS OPERATED BY PANTHEON VENTURES (UK) LLP (THE “INVESTMENT MANAGER“) IN GOOD FAITH AND IS PROVIDED FOR INFORMATION PURPOSES ONLY.

THE INFORMATION CONTAINED ON THIS WEBSITE IS INTENDED ONLY FOR, AND MAY BE ACCESSED ONLY BY, PERSONS IN THE UNITED KINGDOM, PERSONS WHO ARE BOTH WHOLESALE CLIENTS AND PROFESSIONAL OR SOPHISTICATED INVESTORS IN AUSTRALIA AND PERSONS IN ANY OTHER JURISDICTION TO WHOM SUCH INFORMATION CAN BE LAWFULLY COMMUNICATED WITHOUT ANY APPROVAL BEING OBTAINED OR ANY OTHER ACTION BEING TAKEN TO PERMIT SUCH COMMUNICATION WHERE APPROVAL OR OTHER ACTION FOR SUCH PURPOSE IS REQUIRED. THE INFORMATION ON THIS WEBSITE IS NOT DIRECTED AT AND IS NOT FOR USE BY ANY OTHER PERSON AND IT MAY NOT BE LAWFUL TO ACCESS THE INFORMATION IN OTHER JURISDICTIONS.

THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE ITS RELEASE, PUBLICATION OR DISTRIBUTION IS OR MAY BE UNLAWFUL. IN PARTICULAR, THE INFORMATION ON THIS WEBSITE IS NOT DIRECTED AT AND IS NOT FOR USE BY AND MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED TO ANY US PERSON OR ANY PERSON IN CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR AUSTRALIA (OTHER THAN PERSONS WHO ARE BOTH WHOLESALE CLIENTS AND PROFESSIONAL OR SOPHISTICATED INVESTORS IN AUSTRALIA).

Please read this notice carefully – it applies to all persons who view this website. Please note that the terms set out below may be altered or updated without notice. You should read the following provisions in full each time you visit the site.

The information on this website is for information purposes only and does not constitute or form a part of any offer or invitation to sell or issue, or the solicitation of any offer to purchase or subscribe for, securities.

No securities of the Company have been or will be registered under the US Securities Act of 1933, as amended (the “Securities Act“) or under the securities laws of any state or other jurisdiction of the United States and may not be offered, sold or delivered, directly or indirectly, in or into the United States, or to or for the account or benefit of any US person (within the meaning of Regulation S under the Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the US Investment Company Act of 1940, as amended (the “Investment Company Act”). In addition, the Company has not been, and will not be, registered under the Investment Company Act, and as such investors are not and will not be entitled to the benefits of the Investment Company Act. There will be no public offer of securities in the United States.

If you are not permitted to view this website or are in any doubt as to whether you are permitted to view this website, please exit this website immediately by clicking on the “Disagree” button below. The contents of this website must not be released or otherwise forwarded, distributed or sent, directly or indirectly, in whole or in part, outside the United Kingdom, in or into any jurisdiction where the release, forwarding or distribution of such materials would or may breach any applicable law or regulation or would require any registration or licensing within such jurisdiction and in particular not in or into the United States, Canada, the Republic of South Africa, Japan or Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia). Persons receiving any such materials (including, without limitation, custodians, nominees and trustees) should observe these restrictions. Neither the Company, the Investment Manager nor their respective advisers accept any responsibility for any violation by any person of any of these restrictions.

Basis of access 

Access to this website is for information purposes only. Any person seeking access to this website represents and warrants to the Company and to the Investment Manager that they are doing so for information purposes only. Making this website available does not constitute financial product advice, an offer to issue or sell or the solicitation of an offer to subscribe for or buy securities in the Company. Further, it does not constitute a recommendation by the Company or the Investment Manager or any associated company or any other person to subscribe for or buy securities in the Company. The information on this website is general in nature and does not in any way constitute investment, tax, legal or other advice.

None of the Company, the Investment Manager or any other person has, or accepts, any responsibility or duty to update any information, document or announcement contained on this website and the Company reserves the right to add to, remove or amend any information available on this website at any time.

The information on this website is general in nature and may be subject to amendment and updating without notice. None of the Company, the Investment Manager nor any other person guarantees the accuracy or completeness of any information on this website, which may include but is not limited to content that may be considered to be research in nature, and each such person disclaims all representations and warranties, whether express or implied, to the greatest extent permitted by applicable law and regulation. By continuing to use this website, you agree to the exclusion by such persons, to the greatest extent permitted by applicable law and regulation, of any and all liability for any direct, indirect, punitive, consequential, incidental, special or other damages, including, without limitation, loss of profits, revenue or data arising out of or relating to the provision of and your use of this website and its content.

Neither the Company, its directors, the Investment Manager nor any other person accepts any responsibility in respect of any information contained on any other website which may be linked to or from this website.

Further details on the terms on which the Company makes this website available can be found in the Company’s legal and risk notice, which you can view here. You must not proceed further without reviewing the Company’s legal and risk notice.